Arcosa acquired by CRH Americas in $7.5 billion merger, delists from NYSE

Arcosa, Inc. (NYSE:ACA) announced Friday that it has completed its previously disclosed merger with CRH Americas, Inc., a subsidiary of Ireland-based CRH plc. The transaction, which closed Friday, results in Arcosa becoming a wholly owned subsidiary of CRH Americas. The aggregate cash consideration paid to Arcosa shareholders and holders of equity awards was approximately $7.5 billion.The $150 per share acquisition price represents a significant premium for shareholders, who have seen the stock deliver a 60.5% return over the past year. Trading at $149.15 just before the close, shares were nearly at their 52-week high of $149.21. According to InvestingPro analysis, the stock appears on the platform’s Most Overvalued list. For deeper insights into Arcosa’s valuation and performance metrics, investors can access the comprehensive Pro Research Report, available for this and 1,400+ other US equities.

Under the terms of the merger agreement, each outstanding share of Arcosa common stock was converted into the right to receive $150.00 in cash, subject to applicable withholding taxes. Equity awards granted prior to June 21, 2026, became fully vested and were also settled in cash at $150.00 per share, including any accrued but unpaid dividend equivalents.

To finance the acquisition, CRH Americas used proceeds from a $3.25 billion bridge facility, a $2.5 billion term loan facility with J.P. Morgan SE and other lenders, and cash on hand.

In connection with the merger, Arcosa terminated its $700 million senior secured revolving credit facility and $700 million senior secured term loan facility, repaying all outstanding borrowings of approximately $450.1 million. The company did not incur any material early termination fees or penalties related to this repayment.

As a result of the merger, Arcosa requested the suspension of trading and removal of its common stock from listing on both the New York Stock Exchange and NYSE Texas prior to the opening of trading Friday. The company also plans to file to deregister its common stock with the Securities and Exchange Commission and suspend its public reporting obligations.

All members of Arcosa’s board of directors and officers resigned at the effective time of the merger, with directors and officers of the merger subsidiary assuming those roles at Arcosa.

The information in this article is based on a press release statement filed with the Securities and Exchange Commission.

In other recent news, Arcosa Inc. reported its second-quarter earnings, which did not meet Wall Street expectations. The company announced adjusted earnings per share of $1.13, falling short of the analyst consensus of $1.22. Additionally, Arcosa’s revenue for the quarter was $658.7 million, which was below the anticipated $687.5 million but showed a 2% increase compared to the same period last year. Despite these results, Arcosa’s stock saw a rise following the announcement of its pending acquisition by CRH. The acquisition deal, valued at $150 per share in cash, was initially announced in June and is anticipated to finalize in the first quarter of 2027. Arcosa has decided to suspend its financial guidance due to this upcoming merger.